323 related articles for article (PubMed ID: 24373995)
1. Development and in vivo evaluation of papain-functionalized nanoparticles.
Müller C; Perera G; König V; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2014 May; 87(1):125-31. PubMed ID: 24373995
[TBL] [Abstract][Full Text] [Related]
2. Mucus permeating thiomer nanoparticles.
Köllner S; Dünnhaupt S; Waldner C; Hauptstein S; Pereira de Sousa I; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):265-72. PubMed ID: 25603199
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticles decorated with proteolytic enzymes, a promising strategy to overcome the mucus barrier.
Pereira de Sousa I; Cattoz B; Wilcox MD; Griffiths PC; Dalgliesh R; Rogers S; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):257-64. PubMed ID: 25661320
[TBL] [Abstract][Full Text] [Related]
4. Protease-functionalized mucus penetrating microparticles: In-vivo evidence for their potential.
Mahmood A; Laffleur F; Leonaviciute G; Bernkop-Schnürch A
Int J Pharm; 2017 Oct; 532(1):177-184. PubMed ID: 28864390
[TBL] [Abstract][Full Text] [Related]
5. The effect of nanoparticle permeation on the bulk rheological properties of mucus from the small intestine.
Wilcox MD; Van Rooij LK; Chater PI; Pereira de Sousa I; Pearson JP
Eur J Pharm Biopharm; 2015 Oct; 96():484-7. PubMed ID: 25758122
[TBL] [Abstract][Full Text] [Related]
6. Distribution of thiolated mucoadhesive nanoparticles on intestinal mucosa.
Dünnhaupt S; Barthelmes J; Hombach J; Sakloetsakun D; Arkhipova V; Bernkop-Schnürch A
Int J Pharm; 2011 Apr; 408(1-2):191-9. PubMed ID: 21295123
[TBL] [Abstract][Full Text] [Related]
7. Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles.
Yuan H; Chen CY; Chai GH; Du YZ; Hu FQ
Mol Pharm; 2013 May; 10(5):1865-73. PubMed ID: 23495754
[TBL] [Abstract][Full Text] [Related]
8. A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa.
Makhlof A; Werle M; Tozuka Y; Takeuchi H
J Control Release; 2011 Jan; 149(1):81-8. PubMed ID: 20138935
[TBL] [Abstract][Full Text] [Related]
9. Overcoming multiple gastrointestinal barriers by bilayer modified hollow mesoporous silica nanocarriers.
Wang Y; Zhao Y; Cui Y; Zhao Q; Zhang Q; Musetti S; Kinghorn KA; Wang S
Acta Biomater; 2018 Jan; 65():405-416. PubMed ID: 29037897
[TBL] [Abstract][Full Text] [Related]
10. Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral delivery of insulin.
Shan W; Zhu X; Liu M; Li L; Zhong J; Sun W; Zhang Z; Huang Y
ACS Nano; 2015 Mar; 9(3):2345-56. PubMed ID: 25658958
[TBL] [Abstract][Full Text] [Related]
11. Intestinal mucosa permeability following oral insulin delivery using core shell corona nanolipoparticles.
Li X; Guo S; Zhu C; Zhu Q; Gan Y; Rantanen J; Rahbek UL; Hovgaard L; Yang M
Biomaterials; 2013 Dec; 34(37):9678-87. PubMed ID: 24016855
[TBL] [Abstract][Full Text] [Related]
12. Improved Intestinal Mucus Permeation of Vancomycin via Incorporation Into Nanocarrier Containing Papain-Palmitate.
Efiana NA; Dizdarević A; Huck CW; Bernkop-Schnürch A
J Pharm Sci; 2019 Oct; 108(10):3329-3339. PubMed ID: 31136766
[TBL] [Abstract][Full Text] [Related]
13. Mucus permeating self-emulsifying drug delivery systems (SEDDS): About the impact of mucolytic enzymes.
Efiana NA; Phan TNQ; Wicaksono AJ; Bernkop-Schnürch A
Colloids Surf B Biointerfaces; 2018 Jan; 161():228-235. PubMed ID: 29080507
[TBL] [Abstract][Full Text] [Related]
14. Enhanced oral absorption and anticancer efficacy of cabazitaxel by overcoming intestinal mucus and epithelium barriers using surface polyethylene oxide (PEO) decorated positively charged polymer-lipid hybrid nanoparticles.
Ren T; Wang Q; Xu Y; Cong L; Gou J; Tao X; Zhang Y; He H; Yin T; Zhang H; Zhang Y; Tang X
J Control Release; 2018 Jan; 269():423-438. PubMed ID: 29133120
[TBL] [Abstract][Full Text] [Related]
15. Development of an advanced intestinal in vitro triple culture permeability model to study transport of nanoparticles.
Schimpel C; Teubl B; Absenger M; Meindl C; Fröhlich E; Leitinger G; Zimmer A; Roblegg E
Mol Pharm; 2014 Mar; 11(3):808-18. PubMed ID: 24502507
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the cytotoxicity, genotoxicity and mucus permeation capacity of several surface modified poly(anhydride) nanoparticles designed for oral drug delivery.
Iglesias T; López de Cerain A; Irache JM; Martín-Arbella N; Wilcox M; Pearson J; Azqueta A
Int J Pharm; 2017 Jan; 517(1-2):67-79. PubMed ID: 27908629
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of Pluronic(®) F127-modified liposomes and chitosan-modified liposomes for mucus penetration and oral absorption of cyclosporine A in rats.
Chen D; Xia D; Li X; Zhu Q; Yu H; Zhu C; Gan Y
Int J Pharm; 2013 Jun; 449(1-2):1-9. PubMed ID: 23583840
[TBL] [Abstract][Full Text] [Related]
18. Facilitated nanoscale delivery of insulin across intestinal membrane models.
Woitiski CB; Sarmento B; Carvalho RA; Neufeld RJ; Veiga F
Int J Pharm; 2011 Jun; 412(1-2):123-31. PubMed ID: 21501675
[TBL] [Abstract][Full Text] [Related]
19. Methods to determine the interactions of micro- and nanoparticles with mucus.
Grießinger J; Dünnhaupt S; Cattoz B; Griffiths P; Oh S; Borrós i Gómez S; Wilcox M; Pearson J; Gumbleton M; Abdulkarim M; Pereira de Sousa I; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2015 Oct; 96():464-76. PubMed ID: 25641005
[TBL] [Abstract][Full Text] [Related]
20. Virus-Mimicking Mesoporous Silica Nanoparticles with an Electrically Neutral and Hydrophilic Surface to Improve the Oral Absorption of Insulin by Breaking Through Dual Barriers of the Mucus Layer and the Intestinal Epithelium.
Zhang Y; Xiong M; Ni X; Wang J; Rong H; Su Y; Yu S; Mohammad IS; Leung SSY; Hu H
ACS Appl Mater Interfaces; 2021 Apr; 13(15):18077-18088. PubMed ID: 33830730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
